The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Related Articles
Novel Therapies and Combinations Augment Melanoma Treatment Arsenal
Omid Hamid, MD, discusses recent advances in the melanoma treatment landscape and highlights the 21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®.
The first results of ISB 2001, a BCMAxCD38xCD3 targeting trispecific antibody, in R/R myeloma
Hang Quach, MBBS(Hons), SpecCertOC, FRACP, FRCPA, MD, St. Vincent’s Hospital & University of Melbourne, Melbourne, Australia, presents the first results of a Phase I dose…
Weight Changes and Heart Failure After Breast Cancer
This cohort study assesses the role of postdiagnosis and prediagnosis in weight gain in individuals with higher risk for cardiac dysfunction.
Daiichi Sankyo, AstraZeneca Withdraw EU MAA for Dato-DXd in Advanced Nonsquamous NSCLC
European approval is no longer being sought for Dato-DXd in advanced nonsquamous non–small cell lung cancer.
PACE: prognostic and predictive biomarkers in ER+/HER2- advanced breast cancer
Guilherme Nader-Marta, MD, Dana-Farber Cancer Center, Boston, MA, gives an overview of two key studies from the PACE trial (NCT03147287), which explored biomarkers in ER+/HER2-…
Tailor-Made for a Lifelong Pursuit of Precision in Cancer Care
With a focus on closing gaps in cancer care for underserved populations, Joseph A. Sparano, MD, FACP, always strives to put patients first—a quality that…
Predicting Triple-Negative Breast Cancer Immunotherapy… : Oncology Times
An abstract is unavailable.
Clinical Practice Insights Reveal the Complexity of Lymphoma Subtypes and Advances in First-Line Treatments: With Chandler Park, MD; and Joshua Brody, MD
Chandler Park, MD and Joshua Brody, MD discusses treatment challenges posed by the diverse spectrum of lymphomas, ranging from indolent subtypes, to aggressive diseases like…
Blood Podcast | Blood | American Society of Hematology
Blood Podcast | Blood | American Society of Hematology Blood Podcast The editors of Blood are pleased to introduce a podcast series, published weekly…
Examining the AQUILA Trial Presented at ASH 2024
Panelists discuss how the AQUILA trial evaluated whether daratumumab monotherapy provides superior outcomes compared with active monitoring in high-risk smoldering multiple myeloma patients.
